[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Feng Peng Biography and Net Worth

Director of USANA Health Sciences

Mr. Feng Peng is an Independent Director of the Company. Mr. Peng was elected to the Board in May 2016. Mr. Peng has served as a Partner and Portfolio Manager at Linden Rose Investment since January 2017. From March 2013 to December 2016, Mr. Peng served as Chief Financial Officer of Ossen Innovation Co., Ltd., a Chinabased manufacturing company. Prior to that, Mr. Peng served as Senior Vice President at MZ Group from August 2007 until September 2012 where he was responsible for providing strategic consulting services related to U.S. capital markets to Chinese clients. At MZ Group, Mr. Peng conducted extensive financial and industry due diligence, performed analysis on companies financials, and provided management teams of client companies with extensive coaching, including detailed intelligence on investor expectations, perceptions and concerns, industry analysis, compliance, and reporting and disclosure requirements. Prior to working at MZ Group, he served in various capacities at Thomson Financial and Citigroup. Mr. Peng was trained in both finance and accounting. He received a MS in Computer Science from the New Jersey Institute of Technology. He also received a bachelor degree in Automation Control from Shanghai Jiao Tong University in Shanghai, China in 1995. Mr. Peng is a certified Senior International Finance Manager in China. Mr. Peng qualifications to sit on our Board include his extensive business experience in China, as well as his financial and corporate strategy experience.

What is Feng Peng's net worth?: The estimated net worth of Feng Peng is at least $13,127.10 as of March 5th, 2021. Mr. Peng owns 329 shares of USANA Health Sciences stock worth more than $13,127 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Peng may own. Learn More about Feng Peng's net worth.
How do I contact Feng Peng?: The corporate mailing address for Mr. Peng and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on Feng Peng's contact information.
Has Feng Peng been buying or selling shares of USANA Health Sciences?: Feng Peng has not been actively trading shares of USANA Health Sciences within the last three months. Most recently, Feng Peng sold 426 shares of the business's stock in a transaction on Friday, March 5th. The shares were sold at an average price of $100.01, for a transaction totalling $42,604.26. Following the completion of the sale, the director now directly owns 329 shares of the company's stock, valued at $32,903.29. Learn More on Feng Peng's trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 17 times. They sold a total of 65,325 shares worth more than $3,011,529.28. The most recent insider tranaction occured on November, 4th when Director Gilbert A. Fuller sold 675 shares worth more than $25,454.25. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 11/4/2024.

Feng Peng Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2021	Sell	426	$100.01	$42,604.26	329
10/22/2020	Sell	330	$82.81	$27,327.30	1,511
5/29/2020	Sell	658	$83.66	$55,048.28	659
4/28/2020	Sell	282	$83.95	$23,673.90	1,317
12/12/2018	Sell	282	$124.71	$35,168.22
11/27/2018	Sell	282	$120.15	$33,882.30

Feng Peng Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $39.90

$39.50

$40.22

50 Day Range

MA: $37.83

$34.50

$41.29

2 Week Range

Now: $39.90

$34.15

$54.81

Volume

83,195 shs

Average Volume

84,198 shs

Market Capitalization

$760.49 million

P/E Ratio

14.10

Dividend Yield

N/A

Beta

0.89

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.